ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway
Abstract Background: Despite advancements in thyroid cancer (THCA) treatment, the prognosis for advanced cases remains poor. Cellular senescence is crucial…
Abstract Background: Despite advancements in thyroid cancer (THCA) treatment, the prognosis for advanced cases remains poor. Cellular senescence is crucial…
Abstract Background: For premalignant main duct intraductal papillary mucinous neoplasms (MD-IPMN), laparoscopic duodenum and spleen-preserving subtotal or total pancreatectomy (LDSP-STP/TP)…
Abstract Objective: The primary objective of this study is to conduct a comprehensive screening and analysis of differentially expressed genes…